Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can an iPad game spot autism early?

NCT ID NCT03438994

Diagnosis Sponsor: University of Strathclyde Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether an iPad game (Play.Care) could help diagnose autism spectrum disorder (ASD) in children aged 2.5 to 5 years. The game measures how children move while playing, since movement differences may be early signs of autism. Researchers compared the game's results with standard clinical diagnoses in 779 children to see how accurate the game is.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
iPad-based game (Play.Care assessment)
What this could lead to
If successful, this could provide a faster, more objective way to help diagnose autism in young children.
What could go wrong
This is a diagnostic accuracy study, not a treatment trial. The game may not be accurate enough to replace current methods, and results may not apply to all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

779 people

The number who actually took part.

Started

Jan 2018

Finished

Jul 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 months to 5 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

1. Inclusion Criteria: 1. All participants: * Aged 30 months - 5 years inclusive 2. ASD Participants: * Diagnosis of autism spectrum disorder on the basis of DSM-V criteria or equivalent ICD-10 framework (F84): childhood autism (F84.0), atypical autism (F84.1), and Asperger's syndrome (F84.5) 3. OND participants: * Other childhood developmental disorders including, but not limited to, * Attention Deficit Hyperactivity Disorder, * Developmental Coordination Disorder, * Intellectual disability, * Non- verbal disability and * Communication Disability. * Sensory and motor impairments will be included 2. Exclusion Criteria: 1. Typically developing participants: * Diagnosis or suspicion of * Neuropathology * Psychopathology * Sensory or motor disorder including mild tremors 2. ASD participants: * Uncorrected sensory (visual, hearing) impairments * Presence of any motor impairments or behavioural impairment that may obstruct testing 3. OND participants: * Sub-clinical or secondary expressions of ASD * Uncorrected hearing or vision impairments

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autism spectrum disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

autism autism spectrum disorder neurodevelopmental disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Autism spectrum disorder Other neurodevelopmental disorder

Contacts and locations

Locations

  • Gillberg Neuropsychiatry Centre

    Gothenburg, 411 19, Sweden

  • University of Strathclyde

    Glasgow, G, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.